Tapayan, Wishney A.
HRN: 21-54-42 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/24/2022
CEFUROXIME 500MG (TAB)
07/24/2022
07/31/2022
PO
500ng
Q12
Post Op Prophylaxis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: No Wrong Duration Wrong Duration
Overall appropriateness: No Wrong Duration